Company intelligence / Profile preview

Connect BioMed

Ownership: Private
Development stage: Commercial

Overview

Connect BioMed provides digital solutions and services for healthcare, pharmaceutical, and biopharmaceutical companies to streamline the collection, analysis, and sharing of medical conference insights. Their main product, Connect Conference, enables real-time intelligence gathering from scientific meetings for medical affairs and commercial teams[1][2][4].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with 6 of the top 20 global pharmaceutical companies as well as many mid-sized and emerging biopharmaceutical firmsCollaborates with medical societies and patient advocacy organizations

Beyond the preview

Go deeper on Connect BioMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connect BioMed.

Explore the full profile